A phase I/II study of SB-FIX for the treatment of haemophilia B.
Phase of Trial: Phase I/II
Latest Information Update: 06 Mar 2017
Price : $35 *
At a glance
- Drugs SB FIX (Primary)
- Indications Haemophilia B
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2017 New trial record
- 11 Jan 2017 According to the Sangamo Therapeutics media release, company plans to initiate the trial in 2017 and data is expected in late 2017 or early 2018.